[go: up one dir, main page]

AR070026A1 - Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus - Google Patents

Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus

Info

Publication number
AR070026A1
AR070026A1 ARP080103937A ARP080103937A AR070026A1 AR 070026 A1 AR070026 A1 AR 070026A1 AR P080103937 A ARP080103937 A AR P080103937A AR P080103937 A ARP080103937 A AR P080103937A AR 070026 A1 AR070026 A1 AR 070026A1
Authority
AR
Argentina
Prior art keywords
amino
treatment
elements
dosage
alquilciclohexanos
Prior art date
Application number
ARP080103937A
Other languages
English (en)
Inventor
Michael Althaus
Barbara Ellers-Lenz
Hagen Kruger
Erhard Seiller
Ag Novartis
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of AR070026A1 publication Critical patent/AR070026A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente se relaciona con un esquema de dosificacion para la administracion de un derivado de 1-amino-alquilciclohexano que permite alcanzar rápidamente una dosis eficaz de un derivado de 1-amino-alquilciclohexano, y que al mismo tiempo, permite minimizar los efectos colaterales, Además, la presente se relaciona con un conjunto de elementos para dosificacion para proveer un derivado de 1-amino-alquilciclohexano (por ejemplo, neramexano o una sal de éste aceptable para el uso farmacéutico) en al menos dos dosificaciones diferentes. El presente esquema de dosificacion/conjunto de elementos para dosificacion puede ser util en el tratamiento de diversas enfermedades, incluyendo el tinnitus.
ARP080103937A 2007-09-12 2008-09-10 Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus AR070026A1 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US99339607P 2007-09-12 2007-09-12
EP07253630 2007-09-12
US6708308P 2008-02-25 2008-02-25
US6693108P 2008-02-25 2008-02-25
US6702608P 2008-02-25 2008-02-25
EP08004777 2008-03-14
EP08004776 2008-03-14
EP08004778 2008-03-14

Publications (1)

Publication Number Publication Date
AR070026A1 true AR070026A1 (es) 2010-03-10

Family

ID=40451596

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP080103937A AR070026A1 (es) 2007-09-12 2008-09-10 Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
ARP080103936A AR070025A1 (es) 2007-09-12 2008-09-10 Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
ARP080103938A AR071728A1 (es) 2007-09-12 2008-09-10 Terapia con intervalos para el tratamiento del tinnitus

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP080103936A AR070025A1 (es) 2007-09-12 2008-09-10 Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
ARP080103938A AR071728A1 (es) 2007-09-12 2008-09-10 Terapia con intervalos para el tratamiento del tinnitus

Country Status (21)

Country Link
US (6) US9468610B2 (es)
EP (6) EP2200600B1 (es)
JP (6) JP5563461B2 (es)
KR (4) KR20100052558A (es)
CN (4) CN101835469A (es)
AR (3) AR070026A1 (es)
AT (1) ATE532507T1 (es)
AU (4) AU2008298016B2 (es)
BR (2) BRPI0816712A2 (es)
CA (4) CA2699209A1 (es)
DK (1) DK2200600T3 (es)
ES (5) ES2562709T3 (es)
HR (1) HRP20120046T1 (es)
MX (4) MX2010002734A (es)
PL (1) PL2200600T3 (es)
PT (1) PT2200600E (es)
RU (1) RU2011137131A (es)
SI (1) SI2200600T1 (es)
TW (3) TW200927087A (es)
WO (4) WO2009033649A1 (es)
ZA (4) ZA201001261B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100052558A (ko) * 2007-09-12 2010-05-19 메르츠 파마 게엠베하 운트 코. 카가아 네라멕산을 위한 적정 패키지 및 내이 질환의 치료에서의 그의 용도
US20110294890A1 (en) 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
US8980318B2 (en) 2010-06-24 2015-03-17 Merz Pharma Gmbh & Co. Kgaa Neramexane multiple unit dosage form
EP2665474A1 (en) * 2011-01-20 2013-11-27 Merz Pharma GmbH & Co. KGaA Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
CA2904055A1 (en) * 2013-03-06 2014-09-12 Acorda Therapeutics, Inc. Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
CA2946146A1 (en) * 2014-04-28 2015-11-05 Kyorin Pharmaceutical Co., Ltd. Drug for treatment of tinnitus patients
WO2015166918A1 (ja) * 2014-04-28 2015-11-05 杏林製薬株式会社 耳鳴患者の治療用の薬剤
KR102441249B1 (ko) * 2014-10-23 2022-09-08 아레나 파마슈티칼스, 인크. Ｐｇｉ2 수용체 관련 병태의 치료 방법
PL3297628T3 (pl) * 2015-05-18 2021-12-06 Sensorion Azasetron do stosowania w leczeniu niedosłuchu
KR101893604B1 (ko) 2015-08-27 2018-08-30 경희대학교 산학협력단 칸디다 유틸리스 추출물을 포함하는 난청의 예방 또는 치료용 조성물
CN105924362B (zh) * 2016-02-05 2018-08-17 上海龙翔生物医药开发有限公司 芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
KR20220119169A (ko) 2017-03-01 2022-08-26 아레나 파마슈티칼스, 인크. Pgi2-수용체 효능제를 포함하는 조성물 및 그의 제조 방법
EP3796902A1 (en) 2018-05-16 2021-03-31 Arena Pharmaceuticals, Inc. Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
KR102268893B1 (ko) 2020-01-16 2021-06-24 경북대학교 산학협력단 림노트릭스 속 knua002 균주를 포함하는 난청의 예방 또는 치료용 조성물
CN111477199B (zh) * 2020-04-02 2021-11-30 北京瑞迪欧文化传播有限责任公司 一种嵌入式音乐控制系统
EP4297708A4 (en) * 2021-09-09 2024-08-28 Samsung Electronics Co., Ltd. AUDIO CONTENT DELIVERY MANAGEMENT

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811128A (en) 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US4849222A (en) 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5288502A (en) 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
EP0724432B1 (en) 1993-10-22 2002-09-18 Genentech, Inc. Methods and compositions for microencapsulation of antigens for use as vaccines
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
WO1998010757A2 (en) 1996-09-11 1998-03-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
ES2200358T3 (es) 1997-06-30 2004-03-01 MERZ PHARMA GMBH & CO. KGAA 1-amino-alquilciclohexanos antagonistas del receptor de nmda.
US6071966A (en) 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
EE200200612A (et) 2000-04-26 2004-06-15 Warner-Lambert Company Tsükloheksüülamiini derivaadid kui alatüübi selektiivsed NMDA-retseptori antagonistid
DE10048969A1 (de) * 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
US20030236288A1 (en) * 2002-02-28 2003-12-25 Karl Schoenafinger Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase
JP2004021734A (ja) 2002-06-18 2004-01-22 Nokia Corp キーパッドおよびキーパッドシステム
US7086532B2 (en) * 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
CA2497867A1 (en) * 2002-09-06 2004-03-18 Durect Corporation Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
DE10252665A1 (de) 2002-11-11 2004-06-03 Grünenthal GmbH 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
RS20050851A (sr) 2003-05-27 2008-04-04 Forest Laboratories Inc., Kombinacija antagonista nmda receptora i selektivnog inhibitora ponovnog preuzimanja serotonina za lečenje depresije i drugih poremećaja raspoloženja
AR046314A1 (es) 2003-11-05 2005-11-30 Merz Pharma Gmbh & Co Kgaa Composiciones que comprenden ciclohexilaminas y aminoadamantanos
US20060002999A1 (en) 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP2601937A1 (en) 2004-06-17 2013-06-12 Merz Pharma GmbH & Co. KGaA Drinkable immediate release tablet made with direct compression of memantine or neramexane
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
WO2006079055A2 (en) * 2005-01-24 2006-07-27 Neurosystec Corporation Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
EP1861104A4 (en) * 2005-03-04 2011-12-14 Neurosystec Corp IMPROVED GACYCLIDINE FORMULATIONS
TWI265036B (en) * 2005-04-29 2006-11-01 Guo-Ming Huang Safety injector and method of operating the same
WO2006124838A1 (en) * 2005-05-18 2006-11-23 Gt Urological, Llc. Drug elution for implantable incontinence devices
CN1896729A (zh) 2005-07-15 2007-01-17 复旦大学附属中山医院 纳米药物自组装双稳态量子线阵列及其制备方法
US20070141148A1 (en) * 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
TW200819458A (en) * 2006-06-23 2008-05-01 Merz Pharma Gmbh & Co Kgaa Metabotropic glutamate receptor modulators
KR20100052558A (ko) * 2007-09-12 2010-05-19 메르츠 파마 게엠베하 운트 코. 카가아 네라멕산을 위한 적정 패키지 및 내이 질환의 치료에서의 그의 용도
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
TW201006463A (en) * 2008-06-26 2010-02-16 Merz Pharma Gmbh & Co Kgaa Pharmaceutical compositions comprising aminocyclohexane derivatives
WO2010028769A1 (en) * 2008-09-10 2010-03-18 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
EP2665474A1 (en) * 2011-01-20 2013-11-27 Merz Pharma GmbH & Co. KGaA Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss

Also Published As

Publication number Publication date
JP2014221767A (ja) 2014-11-27
PT2200600E (pt) 2012-02-17
AU2008298017B2 (en) 2012-03-01
ZA201001261B (en) 2011-08-31
EP2203163A1 (en) 2010-07-07
US9498450B2 (en) 2016-11-22
MX2010002733A (es) 2010-04-09
CA2699209A1 (en) 2009-03-19
AU2008298018C1 (en) 2012-08-16
KR20100052558A (ko) 2010-05-19
WO2009033651A1 (en) 2009-03-19
AU2008298018B2 (en) 2012-01-19
US20170027885A1 (en) 2017-02-02
JP5563460B2 (ja) 2014-07-30
AR070025A1 (es) 2010-03-10
EP2203163B1 (en) 2014-08-27
BRPI0816690A2 (pt) 2016-11-01
AU2008298018A1 (en) 2009-03-19
EP2386299A2 (en) 2011-11-16
KR20100052556A (ko) 2010-05-19
WO2009033652A1 (en) 2009-03-19
JP2010539115A (ja) 2010-12-16
CA2699210A1 (en) 2009-03-19
EP2548552A2 (en) 2013-01-23
AU2008298015A1 (en) 2009-03-19
AU2008298016A1 (en) 2009-03-19
HRP20120046T1 (hr) 2012-02-29
JP5563461B2 (ja) 2014-07-30
JP5612473B2 (ja) 2014-10-22
CA2699213A1 (en) 2009-03-19
JP5613053B2 (ja) 2014-10-22
ES2377253T3 (es) 2012-03-23
AU2008298015B2 (en) 2012-03-22
TW200922544A (en) 2009-06-01
JP2010539117A (ja) 2010-12-16
CA2699207A1 (en) 2009-03-19
CN101795679A (zh) 2010-08-04
DK2200600T3 (da) 2012-01-23
ES2510565T3 (es) 2014-10-21
ES2562709T3 (es) 2016-03-07
US20150018425A1 (en) 2015-01-15
ZA201001262B (en) 2011-07-27
TW200918042A (en) 2009-05-01
WO2009033650A1 (en) 2009-03-19
CN101835469A (zh) 2010-09-15
AU2008298016B2 (en) 2012-02-02
JP2010539118A (ja) 2010-12-16
EP2200598A1 (en) 2010-06-30
EP2200599A1 (en) 2010-06-30
JP5784188B2 (ja) 2015-09-24
EP2200600B1 (en) 2011-11-09
KR20100052559A (ko) 2010-05-19
US8877814B2 (en) 2014-11-04
EP2200600A1 (en) 2010-06-30
AR071728A1 (es) 2010-07-14
ZA201001264B (en) 2011-07-27
TW200927087A (en) 2009-07-01
BRPI0816712A2 (pt) 2016-11-08
PL2200600T3 (pl) 2012-04-30
MX2010002734A (es) 2010-04-01
WO2009033649A1 (en) 2009-03-19
KR20100052557A (ko) 2010-05-19
US20110077304A1 (en) 2011-03-31
MX2010002736A (es) 2010-04-01
ATE532507T1 (de) 2011-11-15
AU2008298017A1 (en) 2009-03-19
EP2200599B1 (en) 2016-08-31
ES2596262T3 (es) 2017-01-05
ES2604945T3 (es) 2017-03-10
EP2386299B1 (en) 2016-07-13
MX2010002735A (es) 2010-04-01
EP2386299A3 (en) 2012-05-02
SI2200600T1 (sl) 2012-03-30
CN101801365A (zh) 2010-08-11
JP2010539116A (ja) 2010-12-16
US20110086916A1 (en) 2011-04-14
US9468610B2 (en) 2016-10-18
RU2011137131A (ru) 2013-03-20
EP2548552A3 (en) 2013-10-16
EP2548552B1 (en) 2015-11-18
JP2014221766A (ja) 2014-11-27
JP5784189B2 (ja) 2015-09-24
US20100298440A1 (en) 2010-11-25
CN101801366A (zh) 2010-08-11
US20100298441A1 (en) 2010-11-25
ZA201001263B (en) 2011-07-27

Similar Documents

Publication Publication Date Title
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
BR112015029512A8 (pt) derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas
MX2020003415A (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso.
MX2019010354A (es) Derivado de heteroaril[4,3-c]pirimidina-5-amina, metodo de preparacion del mismo y usos medicos del mismo.
NI201900099A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
ECSP19083621A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
UY30559A1 (es) Derivados de morfolino pirimidina, procesos de preparacion, composiciones conteniéndolos y aplicaciones
BR112012009376A2 (pt) composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso
ECSP18073366A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
NI201900098A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
CO6390066A2 (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
ECSP109935A (es) Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k
ECSP19083640A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
MX2015012559A (es) Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
GT201400059A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
PE20150353A1 (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
AR088204A1 (es) Medicamentos para el tratamiento de la rinitis alergica que comprenden un antagonista de pgd2 y un antagonista de histamina
UY29561A1 (es) Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones

Legal Events

Date Code Title Description
FA Abandonment or withdrawal